Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Call us or click below to book your consultation and get back to doing what you lovefaster and stronger
The primary outcome was the incremental cost-effectiveness ratio (ICER), defined as cost per QALY gained, with the willingness-to-pay threshold set at AU$28,000 per QALY [15]
[PMID: 967880] PubMed record related to this compound for laboratory literature review
Ban K, Kim KH, Cho CK, Sauv M, Diamandis EP, Backx PH, Drucker DJ, Husain M: Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor
Youll work with licensed providers, get clear pricing, and receive ongoing support
What are the side effects associated with PT-141
US$ 24.83
US$ 24.48
US$ 26.88
US$ 27.19
